| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
411,649 | 1,123,479 | 682,162 | 556,382 | 1,598,951 |
|
Cost of Revenue
|
-90,533 | -73,040 | -202,739 | -343,768 | -902,639 |
|
Gross Profit
|
321,116 | 1,050,439 | 479,423 | 212,614 | 696,312 |
| Selling, General and Administrative Expenses
|
-113,209 | -157,479 | -337,185 | -468,946 | -488,691 |
|
Research and Development Expenses
|
-294,487 | -342,320 | -391,169 | -737,502 | -1,235,278 |
| Other Income/Expense, Operating
|
0 | 0 | 0 | 427,323 | 382,921 |
|
Operating Income/Expenses
|
-407,696 | -499,799 | -728,354 | -779,125 | -1,341,048 |
|
Total Operating Profit/Loss
|
-86,580 | 550,640 | -248,931 | -566,511 | -644,736 |
| Total Net Finance Income/Expense
|
-21,815 | -22,547 | -20,075 | -14,416 | -19,880 |
| Irregular Income/Expenses
|
-807 | -126,559 | 51,949 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
37,269 | 40,633 | 40,442 | 37,896 | 10,969 |
|
Non-Operating Income/Expenses, Total
|
14,647 | -108,473 | 72,316 | 23,480 | -8,911 |
|
Pretax Income
|
-71,933 | 442,167 | -176,615 | -543,031 | -653,647 |
|
Provision for Income Tax
|
-4,794 | -1,865 | -10,884 | -2,031 | -4,292 |
|
Net Income from Continuing Operations
|
-76,727 | 440,302 | -187,499 | -545,062 | -657,939 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-76,727 | 440,302 | -187,499 | -545,062 | -657,939 |
|
Net Income after Non-Controlling/Minority Interests
|
-76,727 | 440,302 | -187,499 | -545,062 | -657,939 |
|
Net Income Available to Common Stockholders
|
-76,727 | 440,302 | -187,499 | -545,062 | -657,939 |
|
Dilution to Earnings
|
3,190 | 5,442 | 0 | 0 | -- |
|
Diluted Net Income Available to Common Stockholders
|
-73,537 | 445,744 | -187,499 | -545,062 | -657,939 |
| Basic EPS
|
-0.46 | 2.72 | -1.23 | -5.41 | -8.42 |
| Diluted EPS
|
-0.46 | 2.58 | -1.23 | -5.41 | -8.42 |
|
Basic Weighted Average Shares Outstanding
|
163,830.75 | 161,991 | 152,190 | 100,768 | 78,183 |
|
Diluted Weighted Average Shares Outstanding
|
170,154.75 | 173,103 | 152,190 | 100,768 | 78,183 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-50,118 | 464,714 | -156,540 | -528,615 | -633,767 |
|
EBITDA
|
-35,828 | 492,327 | -108,044 | -487,390 | -604,713 |
|
Normalized EBITDA
|
-1,788 | 752,746 | -107,709 | -391,952 | -474,413 |
|
Normalized Income
|
-51,391.03 | 699,622.55 | -187,249.86 | -474,218.37 | -561,269.43 |
|
Total Unusual Items
|
34,040 | 260,419 | 335 | 95,438 | 130,300 |
12/31/2022 - 2/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade